Photosensitive Epilepsy Completed Phase 2 Trials for Carbamazepine (DB00564)

IndicationStatusPhase
DBCOND0039388 (Photosensitive Epilepsy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00894010Photosensitivity Proof of Concept TrialTreatment